These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 19446623

  • 1. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
    Ohshima H, Miyagishima A, Kurita T, Makino Y, Iwao Y, Sonobe T, Itai S.
    Int J Pharm; 2009 Jul 30; 377(1-2):180-4. PubMed ID: 19446623
    [Abstract] [Full Text] [Related]

  • 2. Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols.
    Kamiya S, Kurita T, Miyagishima A, Arakawa M.
    Drug Dev Ind Pharm; 2009 Aug 30; 35(8):1022-8. PubMed ID: 19466885
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipid nanoparticles with no surfactant improve oral absorption rate of poorly water-soluble drug.
    Funakoshi Y, Iwao Y, Noguchi S, Itai S.
    Int J Pharm; 2013 Jul 15; 451(1-2):92-4. PubMed ID: 23624178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Physical properties of griseofulvin-lipid nanoparticles in suspension and their novel interaction mechanism with saccharide during freeze-drying.
    Kamiya S, Kurita T, Miyagishima A, Itai S, Arakawa M.
    Eur J Pharm Biopharm; 2010 Mar 15; 74(3):461-6. PubMed ID: 20018239
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
    Howard MD, Lu X, Jay M, Dziubla TD.
    Drug Dev Ind Pharm; 2012 Oct 15; 38(10):1270-9. PubMed ID: 22235767
    [Abstract] [Full Text] [Related]

  • 16. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS, Ng ML, Kho K, Hadinoto K.
    Int J Pharm; 2011 Feb 14; 404(1-2):289-300. PubMed ID: 21093560
    [Abstract] [Full Text] [Related]

  • 17. Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles.
    Zillies JC, Zwiorek K, Hoffmann F, Vollmar A, Anchordoquy TJ, Winter G, Coester C.
    Eur J Pharm Biopharm; 2008 Oct 14; 70(2):514-21. PubMed ID: 18582569
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
    Ganea GM, Sabliov CM, Ishola AO, Fakayode SO, Warner IM.
    J Nanosci Nanotechnol; 2008 Jan 14; 8(1):280-92. PubMed ID: 18468072
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.